Gsa Capital Partners LLP Rocket Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 37,239 shares of RCKT stock, worth $119,537. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,239
Previous 24,632
51.18%
Holding current value
$119,537
Previous $164,000
44.51%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
257Shares Held
107MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$56.8 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$40.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$21.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.9 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$16.7 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $243M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...